Gary B. Gordon - 29 Jan 2025 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Reporting relationship
Director
Issuer ticker
TLSI
Reported as of
29 Jan 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
31 Jan 2025, 18:03:33 UTC
Prior SEC filing
23 Jan 2023
Next SEC filing
27 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James E. Young, Attorney-in-Fact

Key filing fact

Gary B. Gordon filed Form 3 for TriSalus Life Sciences, Inc. (TLSI) on 31 Jan 2025.

Key facts

  • This page summarizes Gary B. Gordon's Form 3 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Jan 2025, 18:03.

Change

  • Previous filing in this sequence was filed on 23 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .